SÃO PAULO, 3 de novembro de 2023 /PRNewswire/ — Está surgindo no horizonte um futuro mais saudável para as crianças brasileiras. O deputado federal Fábio Teruel (MDB-SP) está à frente de uma missão audaciosa contra a obesidade infantil, apresentando um projeto de lei destinado a reformular a alimentação nas escolas, garantindo mais qualidade, transparência e uma… Continue reading Por uma Infância Saudável: Deputado Fábio Teruel Luta por Menos Açúcar e Mais Nutrientes nas Escolas!
Category: Newswire
Rairdon Automotive Group Amplifies its Footprint with the Launch of its 12th Dealership, now in Everett, WA!
EVERETT, Wash., Nov. 3, 2023 /PRNewswire/ — Celebrating its 30th year of excellence in the automotive dealership sector, Rairdon Automotive Group proudly unveils its newest dealership, Rairdon’s Volkswagen of Everett, rooted in the heart of Everett, WA. This acquisition from the Pignataro Family underscores Rairdon’s unwavering allegiance to the communities it operates in and exemplifies its… Continue reading Rairdon Automotive Group Amplifies its Footprint with the Launch of its 12th Dealership, now in Everett, WA!
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revvity, Inc. – RVTY
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Revvity, Inc. (“Revvity” or the “Company”) (NYSE: RVTY). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Revvity and certain of its officers and/or directors have engaged in securities fraud or other… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revvity, Inc. – RVTY
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biora Therapeutics, Inc. – BIOR
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Biora Therapeutics, Inc. (“Biora” or the “Company”) (NASDAQ: BIOR). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Biora and certain of its officers and/or directors have engaged in securities fraud or… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biora Therapeutics, Inc. – BIOR
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. – KVUE
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Kenvue Inc. (“Kenvue” or the “Company”) (NYSE: KVUE). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Kenvue and certain of its officers and/or directors have engaged in securities fraud or other… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. – KVUE
Compugen Announces Receipt of Nasdaq Minimum Bid Price Notification
HOLON, Israel, Nov. 3, 2023 /PRNewswire/ — Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today that on November 3, 2023, it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that its ordinary shares… Continue reading Compugen Announces Receipt of Nasdaq Minimum Bid Price Notification
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. – LFST
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether LifeStance and certain of its officers and/or directors have engaged in securities… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. – LFST
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adobe, Inc. – ADBE
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Adobe, Inc. (“Adobe” or the “Company”) (NASDAQ: ADBE). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Adobe and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. … Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adobe, Inc. – ADBE
Cboe Global Markets Reports Trading Volume for October 2023
CHICAGO, Nov. 3, 2023 /PRNewswire/ — Cboe Global Markets, Inc. (Cboe: CBOE), the world’s leading derivatives and securities exchange network, today reported October monthly trading volume statistics across its global business lines. The data sheet “Cboe Global Markets Monthly Volume & RPC/Net Revenue Capture Report” contains an overview of certain October trading statistics and market share… Continue reading Cboe Global Markets Reports Trading Volume for October 2023
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH PLAINFIELD, N.J., Nov. 3, 2023 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Nov. 1, 2023, the company approved non-statutory stock options to purchase an aggregate of 14,005 shares of its common stock and 19,125 restricted stock units (“RSUs”), each representing the right to receive one share of its common stock… Continue reading PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)